Hudson Technologies closes out April with a week-one look at what's coming: a May 6 earnings print that has historically punished shareholders, against a backdrop of quietly retreating short interest and borrowing costs sitting near their lowest levels in months.
The most telling feature of the current setup is how much the bear trade has softened compared to just three weeks ago. Short interest peaked around 4.3% of the free float during the early-April tariff jitters, briefly spiking on April 7-8 as macro anxiety gripped small-cap names. That buildup has since fully unwound. SI % FF has eased back to 3.8%, essentially where it was at end-March, and ORTEX's short score has drifted steadily lower all month — from 38.0 on April 15 down to 37.6 now. Short sellers moved into early April, then backed off cleanly.
The borrow market reinforces that picture. Cost to borrow has dropped roughly 30% over the past month to 0.55% — a genuinely cheap rate, near the lowest of the trailing 30 days. Availability is extremely loose at well above 1,000% of short interest, meaning there is ample lending supply relative to what's actually borrowed. The ORTEX short score of 37.6 places HDSN in the lower-conviction short territory. With borrowing this cheap and availability this wide, the lending market carries no squeeze pressure at all. Options positioning echoes the same message: the put/call ratio sits at 0.39, almost exactly in line with its 20-day average of 0.39, and the z-score is essentially flat. No hedging premium, no unusual directional bet — options traders are neutral.
The Street is cautiously constructive but has spent the last several months trimming ambition. After a cluster of target cuts in early March — Canaccord, Roth Capital, and B. Riley all lowered targets following the Q4 print — the consensus price target settles at $9.00. That implies roughly 48% upside from Wednesday's close of $6.08. The P/E ratio has compressed to around 14.5x on trailing earnings, and the EV/EBITDA of 7.1x looks undemanding for a company positioned to benefit from EPA-mandated reclaimed refrigerant rules. The bull case rests on rising HFC refrigerant prices — Q2 2025 saw market prices stabilise around $8 per pound and margins recovering sharply — while bears point to a 3% revenue decline in that same quarter and the risk that slow regulatory progress from the EPA blunts the recovery story. Analyst ratings have not changed since early March, so these targets are now nearly two months old, and the stock has drifted lower since they were set.
The earnings history is blunt. The last four quarterly prints have all produced sharp next-day declines: -12.7% after the most recent Q4 release, -11.1% on the prior occasion, and a -21.1% drop after the November 2025 print. The five-day windows are worse: -16.9%, -18.3%, and -15.2% respectively. There is a consistent pattern of negative near-term price reactions following results, regardless of whether the company technically beats estimates (the EPS surprise factor score ranks in the 93rd percentile of the universe, suggesting beats are common). The market has been penalising the revenue and volume trajectory even when per-share figures hold up.
Institutional ownership is stable. BlackRock, Vanguard, and Dimensional all marginally added in Q1 2026, while no major holder showed a meaningful reduction. The most significant insider transaction on record from recent months was a December sale by director Brian Coleman — nearly $3.6 million at $7.40 — but that came when the stock was trading well above current levels, and no subsequent buying has appeared in the data window. That insider data is now over three months old and should be read as background context rather than fresh signal.
The setup into May 6 is therefore simpler than the history suggests: short sellers have already backed away, borrowing costs give them no reason to rebuild quickly, and the Street holds constructive ratings that haven't moved in nearly two months. What the earnings release will test is whether refrigerant pricing held through Q1, whether revenues showed any recovery from the year-ago decline, and whether management commentary on EPA rulemaking timelines gives the bull case firmer ground.
See the live data behind this article on ORTEX.
Open HDSN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
